Edwards Lifesciences Corp.
Latest From Edwards Lifesciences Corp.
EuroPCR 2018: Real-World TAVR Data Show Consistent Performance With Edwards, Abbott, And Medtronic's Systems
New real-world data on Edward Lifesciences real-world data for its transcatheter aortic valve replacement Sapien 3 valve are among the highlights from the early Hot Line/Late-Breaking Trial sessions at the EuroPCR conference in Paris.
The US agency will convene advisors this summer to reassess whether hospital and practitioner procedure volume requirements, currently a prerequisite for running a Medicare-covered transcatheter aortic heart valve replacement program, are warranted.
Medicare Bonus Payments: CMS Plans To End Three, But Considers Seven New-Tech Add-On Payments For FY 2019
While the US Medicare agency is proposing to end hospital inpatient new-technology add-on payments for Edwards Lifesciences’ and LivaNova’s minimally surgical valves, and for WL Gore's endoprosthesis aneurysm device, it is evaluating possible bonus payments for 7 more devices beginning Oct. 1.
SCAI2018: Innovation In Cardiovascular Interventions From The Cath Lab, Incubators, Robotic PCI, Digital Health
This year's annual meeting of the Society for Cardiovascular Angiography and Interventions' Scientific Sessions is expected to draw nearly 2,000 interventional cardiologists worldwide to San Diego for the four-day meeting ending April 28. Among the highlights of scientific sessions was the all-new Innovations in Cardiovascular Interventions and Technology Summit on April 25, hosted in partnership with Innovations in Cardiovascular Interventions (ICI Israel), which focused on evolving technologies and strategies for innovations. This article rounds up the best Tweets posted by Medtech Insight attending #SAIC2018. It includes presentations on how to create true innovation at an incubator and at big companies like Edwards Lifesciences, new products on the market and US FDA evolution toward medical device evaluation.
- Implantable Devices
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Baxter CardioVascular Group
- North America
- Parent & Subsidiaries
- Edwards Lifesciences Corp.
- Senior Management
Michael A Mussallem, Chmn. & CEO
Scott B Ullem, Corp. VP, CFO
Donald E Bobo, Corp. VP, Strategy & Corp. Dev.
Stanton J Rowe, Corp. VP, Adv. Tech. & CSO
- Contact Info
Edwards Lifesciences Corp.
Phone: (949) 250-2500
1 Edwards Way
Irvine, CA 92614
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.